← Back to TCRX

TScan Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 06/05/2026Sep 2025Filed 12/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 06/05/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 06/05/2025
$1.1$1$2.5$3.1$2.2$1$0.5$0.6
−$30−$29−$36−$37−$34−$30−$32−$30
−$0.23−$0.22−$0.28−$0.28−$0.26−$0.25−$0.28−$0.32
13013013013013011911395

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.